Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Mechanical Thrombectomy in Stroke Could Have Worse Results in Low Volume Centers

The number of centers that are starting endovascular stroke therapy (EST) to treat acute stroke is growing fast, with a significant increase of cases in low volume centers. Interventional neurologists are not able to cover the high demand and interventional cardiologists are always ready to learn something new. Is this right? Should interventional cardiologists treat acute stroke? This study, soon to be published, sheds some light on the matter.

Calidad de vida entre cirugía y angioplastia para tratar la enfermedad del troncoDrastically increasing the number of operators in order to tackle the increasing demand will probably result in more low volume centers, which in turn will translate into poor outcomes, at least in the short term.  

 

We should not cut corners when it comes to training, and perhaps an interventional cardiologist interested in collaborating with interventional neurologists should reconsider their fellowship.

 

The chances of getting good results (defined as discharging patients and sending them home with total autonomy) is significantly higher in centers that perform many thrombectomy procedures a year.  


Read also: NOTION and UK TAVI Report Good Long-Term Outcomes.


Findings support the idea that the most recent thrombectomy study outcomes are partial.

 

Interventional neurologists have long resisted the idea of involving interventional cardiologists, and though they offer solutions such as chopper transfers to high volume centers or mobile stroke units, developing countries, such as Latin American countries, are far from being able to use choppers to transport patients.

 

There are several points to be taken into consideration when it comes to determining what is best. On the one hand, EST has been shown superior to medical therapy in high volume centers, tertiary centers with advanced neuroimaging technology, neurosurgeons, neuro-interventionists, and critical neurology and nursing care units.


Read also: Un Underestimated Symptom of Aortic Stenosis.


On the other hand, any delay or deviation from this translates into poor outcomes, even worse than letting nature follow its course.  

 

This study analyzed 3890 patients treated in the state of Florida between 2006 and 2016, and 42505 treated across the US between 2012 and 2016.

 

The number of procedures increased steadily year after year, peaked in 2015, and then levelled off.

 

Looking at Florida data, 87% of procedures performed in 2008 were concentrated in 8 large volume centers, but this proportion had fallen to 45% by 2016. By the end of the study, up to 25% of cases were performed in centers with a 20-case annual volume.

 

The problem of EST is clear, the answer is not.

 

Interventional cardiologists keep lurking, perhaps overly confident, relying too much on our manual dexterity while we disregard the fact that we venture in unknown vascular territory.

 

Original title: Real-World Treatment Trends in Endovascular Stroke Therapy.

Reference: Saber H et al. Stroke. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...